Valuation: Neuland Laboratories Limited

Market Cap 243B 2.52B 2.21B 2.04B 1.88B 3.54B 3.6B 24.41B 9.57B 119B 9.46B 9.26B 410B P/E 2027 *
58x
P/E 2028 * 42x
Enterprise Value 246B 2.55B 2.24B 2.07B 1.9B 3.59B 3.64B 24.71B 9.69B 120B 9.58B 9.37B 415B EV / Sales 2027 *
10.7x
EV / Sales 2028 * 8.81x
Free-Float
62.24%
Yield 2027 *
0.07%
Yield 2028 * 0.1%
1 day+2.82%
1 week-2.94%
Current month+1.67%
1 month+9.18%
3 months+23.79%
6 months+36.28%
Current year+24.70%
1 week 18,041.55
Extreme 18041.55
19,355.2
1 month 17,032.7
Extreme 17032.7
20,072
Current year 11,500
Extreme 11500
20,072
1 year 11,500
Extreme 11500
20,072
3 years 3,100.05
Extreme 3100.05
20,072
5 years 965.85
Extreme 965.85
20,072
10 years 247.3
Extreme 247.3
20,072
Manager TitleAgeSince
Chief Executive Officer 46 31/03/2026
Director of Finance/CFO - 22/11/2022
Chief Tech/Sci/R&D Officer - 28/02/2023
Director TitleAgeSince
Director/Board Member - 31/07/2025
Director/Board Member 80 30/10/2022
Director/Board Member 82 11/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
+2.82%-2.94%+32.98%+504.69% 2.45B
-2.34%-1.59%+52.60%+150.76% 1,051B
-1.39%-3.05%+52.04%+48.41% 609B
-0.68%+2.11%+36.99%+78.09% 450B
-0.75%+0.30%+29.77%+21.15% 330B
-1.52%-1.19%+34.46%+35.35% 284B
-1.70%-1.82%+20.99%+15.74% 263B
-0.58%+1.11%-20.18%-40.59% 223B
-0.65%+1.34%+23.46%+56.62% 198B
-0.72%+1.69%+23.40%+67.14% 167B
Average -0.60%-0.07%+28.65%+93.74% 357.75B
Weighted average by Cap. -1.15%+0.02%+37.14%+72.35%

Financials

2027 *2028 *
Net sales 23.09B 239M 210M 194M 178M 337M 342M 2.32B 909M 11.3B 899M 879M 38.92B 27.8B 288M 253M 234M 215M 405M 412M 2.79B 1.09B 13.6B 1.08B 1.06B 46.86B
Net income 4.21B 43.65M 38.26M 35.37M 32.53M 61.37M 62.36M 423M 166M 2.06B 164M 160M 7.1B 5.81B 60.21M 52.77M 48.78M 44.86M 84.65M 86M 583M 229M 2.84B 226M 221M 9.79B
Net Debt 2.94B 30.46M 26.7M 24.68M 22.7M 42.83M 43.51M 295M 116M 1.44B 114M 112M 4.95B 1.92B 19.91M 17.45M 16.13M 14.84M 28M 28.45M 193M 75.62M 940M 74.78M 73.14M 3.24B
Logo Neuland Laboratories Limited
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Employees
2,183
Date Price Change Volume
20/07/26 18,942.05 +2.82% 10,883
17/07/26 ₹18,422.80 -1.87% 1,641
16/07/26 ₹18,773.60 -1.66% 943
15/07/26 ₹19,089.60 +0.48% 625
14/07/26 ₹18,997.85 -0.01% 514
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
18,942.05INR
Average target price
21,222.00INR
Spread / Average Target
+12.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NEULANDLAB Stock